nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—UGT2B7—Epirubicin—uterine cancer	0.0765	0.112	CbGbCtD
Lovastatin—UGT1A1—Etoposide—uterine cancer	0.0515	0.0758	CbGbCtD
Lovastatin—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0509	0.0749	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0467	0.0688	CbGbCtD
Lovastatin—CYP3A7—Progesterone—uterine cancer	0.0467	0.0688	CbGbCtD
Lovastatin—ABCC2—Carboplatin—uterine cancer	0.0373	0.0549	CbGbCtD
Lovastatin—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0355	0.0522	CbGbCtD
Lovastatin—CYP3A5—Progesterone—uterine cancer	0.0351	0.0516	CbGbCtD
Lovastatin—CYP2C8—Progesterone—uterine cancer	0.0337	0.0496	CbGbCtD
Lovastatin—ABCC2—Etoposide—uterine cancer	0.0313	0.0461	CbGbCtD
Lovastatin—CYP2C19—Progesterone—uterine cancer	0.0283	0.0416	CbGbCtD
Lovastatin—CYP2C9—Progesterone—uterine cancer	0.0235	0.0346	CbGbCtD
Lovastatin—ABCB1—Progesterone—uterine cancer	0.0228	0.0336	CbGbCtD
Lovastatin—CYP2D6—Progesterone—uterine cancer	0.0215	0.0316	CbGbCtD
Lovastatin—ABCC2—Doxorubicin—uterine cancer	0.0214	0.0314	CbGbCtD
Lovastatin—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0206	0.0304	CbGbCtD
Lovastatin—ABCB1—Dactinomycin—uterine cancer	0.0181	0.0266	CbGbCtD
Lovastatin—CYP3A5—Etoposide—uterine cancer	0.0157	0.0231	CbGbCtD
Lovastatin—CYP2C8—Etoposide—uterine cancer	0.0151	0.0222	CbGbCtD
Lovastatin—CYP3A4—Progesterone—uterine cancer	0.0137	0.0201	CbGbCtD
Lovastatin—ABCB1—Etoposide—uterine cancer	0.0102	0.015	CbGbCtD
Lovastatin—ABCB1—Doxorubicin—uterine cancer	0.00696	0.0102	CbGbCtD
Lovastatin—CYP2D6—Doxorubicin—uterine cancer	0.00656	0.00966	CbGbCtD
Lovastatin—CYP3A4—Etoposide—uterine cancer	0.00612	0.009	CbGbCtD
Lovastatin—HDAC2—oviduct—uterine cancer	0.00526	0.0597	CbGeAlD
Lovastatin—ITGAL—myometrium—uterine cancer	0.00421	0.0478	CbGeAlD
Lovastatin—CYP3A4—Doxorubicin—uterine cancer	0.00417	0.00614	CbGbCtD
Lovastatin—ITGAL—epithelium—uterine cancer	0.0033	0.0375	CbGeAlD
Lovastatin—ITGAL—uterine cervix—uterine cancer	0.00328	0.0372	CbGeAlD
Lovastatin—PON3—uterine cervix—uterine cancer	0.00321	0.0365	CbGeAlD
Lovastatin—ITGAL—decidua—uterine cancer	0.00312	0.0354	CbGeAlD
Lovastatin—HDAC2—exocrine gland—uterine cancer	0.00304	0.0345	CbGeAlD
Lovastatin—ITGAL—endometrium—uterine cancer	0.00296	0.0336	CbGeAlD
Lovastatin—ITGAL—mammalian vulva—uterine cancer	0.00287	0.0325	CbGeAlD
Lovastatin—PON3—mammalian vulva—uterine cancer	0.00281	0.0319	CbGeAlD
Lovastatin—ITGAL—female gonad—uterine cancer	0.00223	0.0253	CbGeAlD
Lovastatin—ITGAL—vagina—uterine cancer	0.00222	0.0252	CbGeAlD
Lovastatin—PON3—female gonad—uterine cancer	0.00219	0.0249	CbGeAlD
Lovastatin—PON3—vagina—uterine cancer	0.00218	0.0247	CbGeAlD
Lovastatin—HDAC2—Teniposide—Etoposide—uterine cancer	0.00213	0.73	CbGdCrCtD
Lovastatin—HMGCR—myometrium—uterine cancer	0.00152	0.0172	CbGeAlD
Lovastatin—UGT2B7—renal system—uterine cancer	0.0015	0.017	CbGeAlD
Lovastatin—ITGAL—lymph node—uterine cancer	0.00144	0.0163	CbGeAlD
Lovastatin—HDAC2—epithelium—uterine cancer	0.00132	0.015	CbGeAlD
Lovastatin—HDAC2—uterine cervix—uterine cancer	0.00131	0.0149	CbGeAlD
Lovastatin—UGT1A1—renal system—uterine cancer	0.00127	0.0144	CbGeAlD
Lovastatin—HDAC2—smooth muscle tissue—uterine cancer	0.00127	0.0144	CbGeAlD
Lovastatin—HDAC2—decidua—uterine cancer	0.00125	0.0142	CbGeAlD
Lovastatin—HDAC2—renal system—uterine cancer	0.00123	0.0139	CbGeAlD
Lovastatin—UGT2B7—female reproductive system—uterine cancer	0.0012	0.0136	CbGeAlD
Lovastatin—HMGCR—epithelium—uterine cancer	0.00119	0.0135	CbGeAlD
Lovastatin—HDAC2—endometrium—uterine cancer	0.00118	0.0134	CbGeAlD
Lovastatin—HMGCR—uterine cervix—uterine cancer	0.00118	0.0134	CbGeAlD
Lovastatin—HMGCR—smooth muscle tissue—uterine cancer	0.00115	0.013	CbGeAlD
Lovastatin—HMGCR—decidua—uterine cancer	0.00113	0.0128	CbGeAlD
Lovastatin—HMGCR—renal system—uterine cancer	0.00111	0.0125	CbGeAlD
Lovastatin—HDAC2—uterus—uterine cancer	0.00109	0.0124	CbGeAlD
Lovastatin—HMGCR—endometrium—uterine cancer	0.00107	0.0121	CbGeAlD
Lovastatin—SLCO1B1—renal system—uterine cancer	0.00106	0.012	CbGeAlD
Lovastatin—HMGCR—mammalian vulva—uterine cancer	0.00103	0.0117	CbGeAlD
Lovastatin—HMGCR—uterus—uterine cancer	0.000985	0.0112	CbGeAlD
Lovastatin—HDAC2—female reproductive system—uterine cancer	0.000981	0.0111	CbGeAlD
Lovastatin—HDAC2—female gonad—uterine cancer	0.000893	0.0101	CbGeAlD
Lovastatin—HDAC2—vagina—uterine cancer	0.000887	0.0101	CbGeAlD
Lovastatin—HMGCR—female reproductive system—uterine cancer	0.000885	0.01	CbGeAlD
Lovastatin—SLCO1A2—renal system—uterine cancer	0.000862	0.00978	CbGeAlD
Lovastatin—SLCO1B1—female reproductive system—uterine cancer	0.000848	0.00963	CbGeAlD
Lovastatin—HMGCR—female gonad—uterine cancer	0.000806	0.00914	CbGeAlD
Lovastatin—ABCC2—renal system—uterine cancer	0.000803	0.00911	CbGeAlD
Lovastatin—HMGCR—vagina—uterine cancer	0.000801	0.00909	CbGeAlD
Lovastatin—HDAC2—Levonorgestrel—Progesterone—uterine cancer	0.000787	0.269	CbGdCrCtD
Lovastatin—ABCC2—female reproductive system—uterine cancer	0.000643	0.0073	CbGeAlD
Lovastatin—CYP2C8—renal system—uterine cancer	0.000602	0.00683	CbGeAlD
Lovastatin—CYP2C8—endometrium—uterine cancer	0.000582	0.00661	CbGeAlD
Lovastatin—CYP3A5—uterine cervix—uterine cancer	0.000581	0.00659	CbGeAlD
Lovastatin—HDAC2—lymph node—uterine cancer	0.000574	0.00651	CbGeAlD
Lovastatin—CYP3A5—renal system—uterine cancer	0.000544	0.00617	CbGeAlD
Lovastatin—HMGCR—lymph node—uterine cancer	0.000518	0.00588	CbGeAlD
Lovastatin—CYP2C19—vagina—uterine cancer	0.0005	0.00567	CbGeAlD
Lovastatin—CYP2C8—female reproductive system—uterine cancer	0.000482	0.00547	CbGeAlD
Lovastatin—CYP2C8—vagina—uterine cancer	0.000436	0.00495	CbGeAlD
Lovastatin—CYP2C9—female reproductive system—uterine cancer	0.000428	0.00486	CbGeAlD
Lovastatin—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000416	0.00269	CcSEcCtD
Lovastatin—Insomnia—Progesterone—uterine cancer	0.000415	0.00268	CcSEcCtD
Lovastatin—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000413	0.00267	CcSEcCtD
Lovastatin—Paraesthesia—Progesterone—uterine cancer	0.000412	0.00266	CcSEcCtD
Lovastatin—Chills—Dactinomycin—uterine cancer	0.00041	0.00265	CcSEcCtD
Lovastatin—Dyspnoea—Progesterone—uterine cancer	0.000409	0.00264	CcSEcCtD
Lovastatin—CYP3A4—renal system—uterine cancer	0.000408	0.00463	CbGeAlD
Lovastatin—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000407	0.00263	CcSEcCtD
Lovastatin—Dyspepsia—Progesterone—uterine cancer	0.000404	0.00261	CcSEcCtD
Lovastatin—Alopecia—Dactinomycin—uterine cancer	0.000404	0.00261	CcSEcCtD
Lovastatin—CYP2D6—renal system—uterine cancer	0.000401	0.00456	CbGeAlD
Lovastatin—Decreased appetite—Progesterone—uterine cancer	0.000399	0.00258	CcSEcCtD
Lovastatin—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000397	0.00256	CcSEcCtD
Lovastatin—ABCB1—myometrium—uterine cancer	0.000397	0.0045	CbGeAlD
Lovastatin—CYP3A5—female gonad—uterine cancer	0.000396	0.00449	CbGeAlD
Lovastatin—Fatigue—Progesterone—uterine cancer	0.000396	0.00256	CcSEcCtD
Lovastatin—CYP3A5—vagina—uterine cancer	0.000394	0.00447	CbGeAlD
Lovastatin—Pain—Progesterone—uterine cancer	0.000393	0.00254	CcSEcCtD
Lovastatin—Constipation—Progesterone—uterine cancer	0.000393	0.00254	CcSEcCtD
Lovastatin—Jaundice cholestatic—Doxorubicin—uterine cancer	0.000389	0.00251	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000379	0.00245	CcSEcCtD
Lovastatin—Feeling abnormal—Progesterone—uterine cancer	0.000378	0.00244	CcSEcCtD
Lovastatin—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000376	0.00243	CcSEcCtD
Lovastatin—ABCC2—lymph node—uterine cancer	0.000376	0.00427	CbGeAlD
Lovastatin—Gastrointestinal pain—Progesterone—uterine cancer	0.000376	0.00242	CcSEcCtD
Lovastatin—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000374	0.00241	CcSEcCtD
Lovastatin—Musculoskeletal pain—Epirubicin—uterine cancer	0.000374	0.00241	CcSEcCtD
Lovastatin—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000371	0.0024	CcSEcCtD
Lovastatin—Phosphatase alkaline increased—Epirubicin—uterine cancer	0.000369	0.00238	CcSEcCtD
Lovastatin—Ill-defined disorder—Dactinomycin—uterine cancer	0.000369	0.00238	CcSEcCtD
Lovastatin—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000366	0.00237	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.000365	0.00236	CcSEcCtD
Lovastatin—Urticaria—Progesterone—uterine cancer	0.000365	0.00236	CcSEcCtD
Lovastatin—Abdominal pain—Progesterone—uterine cancer	0.000363	0.00234	CcSEcCtD
Lovastatin—Body temperature increased—Progesterone—uterine cancer	0.000363	0.00234	CcSEcCtD
Lovastatin—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000362	0.00234	CcSEcCtD
Lovastatin—Neuropathy peripheral—Etoposide—uterine cancer	0.000361	0.00233	CcSEcCtD
Lovastatin—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000359	0.00232	CcSEcCtD
Lovastatin—Malaise—Dactinomycin—uterine cancer	0.000359	0.00232	CcSEcCtD
Lovastatin—Leukopenia—Dactinomycin—uterine cancer	0.000356	0.0023	CcSEcCtD
Lovastatin—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000356	0.0023	CcSEcCtD
Lovastatin—Musculoskeletal pain—Doxorubicin—uterine cancer	0.000346	0.00223	CcSEcCtD
Lovastatin—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000343	0.00221	CcSEcCtD
Lovastatin—Phosphatase alkaline increased—Doxorubicin—uterine cancer	0.000342	0.00221	CcSEcCtD
Lovastatin—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00034	0.0022	CcSEcCtD
Lovastatin—Myalgia—Dactinomycin—uterine cancer	0.000339	0.00219	CcSEcCtD
Lovastatin—Hypersensitivity—Progesterone—uterine cancer	0.000338	0.00218	CcSEcCtD
Lovastatin—Discomfort—Dactinomycin—uterine cancer	0.000335	0.00216	CcSEcCtD
Lovastatin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000331	0.00213	CcSEcCtD
Lovastatin—Asthenia—Progesterone—uterine cancer	0.00033	0.00213	CcSEcCtD
Lovastatin—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000329	0.00212	CcSEcCtD
Lovastatin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000329	0.00212	CcSEcCtD
Lovastatin—CYP3A4—female reproductive system—uterine cancer	0.000327	0.00371	CbGeAlD
Lovastatin—Pruritus—Progesterone—uterine cancer	0.000325	0.0021	CcSEcCtD
Lovastatin—Infection—Dactinomycin—uterine cancer	0.000323	0.00208	CcSEcCtD
Lovastatin—CYP2D6—female reproductive system—uterine cancer	0.000321	0.00365	CbGeAlD
Lovastatin—Thrombocytopenia—Dactinomycin—uterine cancer	0.000318	0.00205	CcSEcCtD
Lovastatin—Diarrhoea—Progesterone—uterine cancer	0.000314	0.00203	CcSEcCtD
Lovastatin—Erythema multiforme—Etoposide—uterine cancer	0.000313	0.00202	CcSEcCtD
Lovastatin—ABCB1—epithelium—uterine cancer	0.000311	0.00353	CbGeAlD
Lovastatin—Anorexia—Dactinomycin—uterine cancer	0.000309	0.002	CcSEcCtD
Lovastatin—ABCB1—uterine cervix—uterine cancer	0.000309	0.0035	CbGeAlD
Lovastatin—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	0.000308	0.00199	CcSEcCtD
Lovastatin—Flushing—Etoposide—uterine cancer	0.000307	0.00198	CcSEcCtD
Lovastatin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000307	0.00198	CcSEcCtD
Lovastatin—Hepatic function abnormal—Epirubicin—uterine cancer	0.000307	0.00198	CcSEcCtD
Lovastatin—Photosensitivity—Epirubicin—uterine cancer	0.000305	0.00197	CcSEcCtD
Lovastatin—Dizziness—Progesterone—uterine cancer	0.000304	0.00196	CcSEcCtD
Lovastatin—Vascular purpura—Epirubicin—uterine cancer	0.0003	0.00193	CcSEcCtD
Lovastatin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000299	0.00193	CcSEcCtD
Lovastatin—Hepatic failure—Epirubicin—uterine cancer	0.000298	0.00192	CcSEcCtD
Lovastatin—Chills—Etoposide—uterine cancer	0.000297	0.00192	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000296	0.00191	CcSEcCtD
Lovastatin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000294	0.0019	CcSEcCtD
Lovastatin—ABCB1—decidua—uterine cancer	0.000294	0.00334	CbGeAlD
Lovastatin—CYP2D6—female gonad—uterine cancer	0.000293	0.00332	CbGeAlD
Lovastatin—Alopecia—Etoposide—uterine cancer	0.000292	0.00189	CcSEcCtD
Lovastatin—Vomiting—Progesterone—uterine cancer	0.000292	0.00189	CcSEcCtD
Lovastatin—Rash—Progesterone—uterine cancer	0.00029	0.00187	CcSEcCtD
Lovastatin—Dermatitis—Progesterone—uterine cancer	0.000289	0.00187	CcSEcCtD
Lovastatin—ABCB1—renal system—uterine cancer	0.000289	0.00328	CbGeAlD
Lovastatin—Headache—Progesterone—uterine cancer	0.000288	0.00186	CcSEcCtD
Lovastatin—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.000285	0.00184	CcSEcCtD
Lovastatin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000285	0.00184	CcSEcCtD
Lovastatin—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000284	0.00183	CcSEcCtD
Lovastatin—Photosensitivity—Doxorubicin—uterine cancer	0.000282	0.00182	CcSEcCtD
Lovastatin—Decreased appetite—Dactinomycin—uterine cancer	0.000282	0.00182	CcSEcCtD
Lovastatin—Dysgeusia—Etoposide—uterine cancer	0.000282	0.00182	CcSEcCtD
Lovastatin—Fatigue—Dactinomycin—uterine cancer	0.00028	0.00181	CcSEcCtD
Lovastatin—ABCB1—endometrium—uterine cancer	0.000279	0.00317	CbGeAlD
Lovastatin—Back pain—Etoposide—uterine cancer	0.000278	0.0018	CcSEcCtD
Lovastatin—Purpura—Epirubicin—uterine cancer	0.000278	0.00179	CcSEcCtD
Lovastatin—Pain—Dactinomycin—uterine cancer	0.000278	0.00179	CcSEcCtD
Lovastatin—Vascular purpura—Doxorubicin—uterine cancer	0.000277	0.00179	CcSEcCtD
Lovastatin—Muscle spasms—Etoposide—uterine cancer	0.000277	0.00179	CcSEcCtD
Lovastatin—Hepatic failure—Doxorubicin—uterine cancer	0.000276	0.00178	CcSEcCtD
Lovastatin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000275	0.00178	CcSEcCtD
Lovastatin—Nausea—Progesterone—uterine cancer	0.000273	0.00176	CcSEcCtD
Lovastatin—ABCB1—mammalian vulva—uterine cancer	0.00027	0.00306	CbGeAlD
Lovastatin—Pain in extremity—Epirubicin—uterine cancer	0.000268	0.00173	CcSEcCtD
Lovastatin—Feeling abnormal—Dactinomycin—uterine cancer	0.000268	0.00173	CcSEcCtD
Lovastatin—Ill-defined disorder—Etoposide—uterine cancer	0.000267	0.00172	CcSEcCtD
Lovastatin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000265	0.00171	CcSEcCtD
Lovastatin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000265	0.00171	CcSEcCtD
Lovastatin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000262	0.00169	CcSEcCtD
Lovastatin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000262	0.00169	CcSEcCtD
Lovastatin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000261	0.00168	CcSEcCtD
Lovastatin—Malaise—Etoposide—uterine cancer	0.00026	0.00168	CcSEcCtD
Lovastatin—Vertigo—Etoposide—uterine cancer	0.000259	0.00167	CcSEcCtD
Lovastatin—Leukopenia—Etoposide—uterine cancer	0.000258	0.00166	CcSEcCtD
Lovastatin—Purpura—Doxorubicin—uterine cancer	0.000257	0.00166	CcSEcCtD
Lovastatin—ABCB1—uterus—uterine cancer	0.000257	0.00292	CbGeAlD
Lovastatin—Abdominal pain—Dactinomycin—uterine cancer	0.000257	0.00166	CcSEcCtD
Lovastatin—Body temperature increased—Dactinomycin—uterine cancer	0.000257	0.00166	CcSEcCtD
Lovastatin—Pain in extremity—Doxorubicin—uterine cancer	0.000248	0.0016	CcSEcCtD
Lovastatin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000247	0.0016	CcSEcCtD
Lovastatin—Chest pain—Etoposide—uterine cancer	0.000245	0.00158	CcSEcCtD
Lovastatin—Discomfort—Etoposide—uterine cancer	0.000242	0.00156	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000241	0.00156	CcSEcCtD
Lovastatin—Hypersensitivity—Dactinomycin—uterine cancer	0.000239	0.00154	CcSEcCtD
Lovastatin—Confusional state—Etoposide—uterine cancer	0.000237	0.00153	CcSEcCtD
Lovastatin—Anaphylactic shock—Etoposide—uterine cancer	0.000235	0.00152	CcSEcCtD
Lovastatin—Infection—Etoposide—uterine cancer	0.000233	0.00151	CcSEcCtD
Lovastatin—Asthenia—Dactinomycin—uterine cancer	0.000233	0.0015	CcSEcCtD
Lovastatin—Influenza—Epirubicin—uterine cancer	0.000232	0.0015	CcSEcCtD
Lovastatin—ABCB1—female reproductive system—uterine cancer	0.000231	0.00262	CbGeAlD
Lovastatin—Thrombocytopenia—Etoposide—uterine cancer	0.00023	0.00149	CcSEcCtD
Lovastatin—Eosinophilia—Epirubicin—uterine cancer	0.000229	0.00148	CcSEcCtD
Lovastatin—Pancreatitis—Epirubicin—uterine cancer	0.000227	0.00147	CcSEcCtD
Lovastatin—Anorexia—Etoposide—uterine cancer	0.000224	0.00145	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000223	0.00144	CcSEcCtD
Lovastatin—Diarrhoea—Dactinomycin—uterine cancer	0.000222	0.00143	CcSEcCtD
Lovastatin—Influenza—Doxorubicin—uterine cancer	0.000214	0.00138	CcSEcCtD
Lovastatin—Eosinophilia—Doxorubicin—uterine cancer	0.000212	0.00137	CcSEcCtD
Lovastatin—Photosensitivity reaction—Epirubicin—uterine cancer	0.000211	0.00136	CcSEcCtD
Lovastatin—Paraesthesia—Etoposide—uterine cancer	0.000211	0.00136	CcSEcCtD
Lovastatin—ABCB1—female gonad—uterine cancer	0.00021	0.00239	CbGeAlD
Lovastatin—Pancreatitis—Doxorubicin—uterine cancer	0.00021	0.00136	CcSEcCtD
Lovastatin—Dyspnoea—Etoposide—uterine cancer	0.000209	0.00135	CcSEcCtD
Lovastatin—ABCB1—vagina—uterine cancer	0.000209	0.00237	CbGeAlD
Lovastatin—Vomiting—Dactinomycin—uterine cancer	0.000206	0.00133	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000205	0.00132	CcSEcCtD
Lovastatin—Rash—Dactinomycin—uterine cancer	0.000205	0.00132	CcSEcCtD
Lovastatin—Decreased appetite—Etoposide—uterine cancer	0.000204	0.00132	CcSEcCtD
Lovastatin—Fatigue—Etoposide—uterine cancer	0.000203	0.00131	CcSEcCtD
Lovastatin—Neuropathy peripheral—Epirubicin—uterine cancer	0.000202	0.00131	CcSEcCtD
Lovastatin—Constipation—Etoposide—uterine cancer	0.000201	0.0013	CcSEcCtD
Lovastatin—Pain—Etoposide—uterine cancer	0.000201	0.0013	CcSEcCtD
Lovastatin—Urinary tract infection—Epirubicin—uterine cancer	0.000201	0.0013	CcSEcCtD
Lovastatin—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000196	0.00126	CcSEcCtD
Lovastatin—Sinusitis—Epirubicin—uterine cancer	0.000194	0.00125	CcSEcCtD
Lovastatin—Feeling abnormal—Etoposide—uterine cancer	0.000194	0.00125	CcSEcCtD
Lovastatin—Nausea—Dactinomycin—uterine cancer	0.000193	0.00124	CcSEcCtD
Lovastatin—Gastrointestinal pain—Etoposide—uterine cancer	0.000192	0.00124	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000189	0.00122	CcSEcCtD
Lovastatin—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000187	0.00121	CcSEcCtD
Lovastatin—Urticaria—Etoposide—uterine cancer	0.000187	0.0012	CcSEcCtD
Lovastatin—Abdominal pain—Etoposide—uterine cancer	0.000186	0.0012	CcSEcCtD
Lovastatin—Body temperature increased—Etoposide—uterine cancer	0.000186	0.0012	CcSEcCtD
Lovastatin—Urinary tract infection—Doxorubicin—uterine cancer	0.000186	0.0012	CcSEcCtD
Lovastatin—Hepatitis—Epirubicin—uterine cancer	0.000185	0.0012	CcSEcCtD
Lovastatin—Sinusitis—Doxorubicin—uterine cancer	0.000179	0.00116	CcSEcCtD
Lovastatin—Erythema multiforme—Epirubicin—uterine cancer	0.000175	0.00113	CcSEcCtD
Lovastatin—Hypersensitivity—Etoposide—uterine cancer	0.000173	0.00112	CcSEcCtD
Lovastatin—Flushing—Epirubicin—uterine cancer	0.000172	0.00111	CcSEcCtD
Lovastatin—Hepatitis—Doxorubicin—uterine cancer	0.000172	0.00111	CcSEcCtD
Lovastatin—Asthenia—Etoposide—uterine cancer	0.000169	0.00109	CcSEcCtD
Lovastatin—Chills—Epirubicin—uterine cancer	0.000166	0.00107	CcSEcCtD
Lovastatin—Pruritus—Etoposide—uterine cancer	0.000166	0.00107	CcSEcCtD
Lovastatin—Alopecia—Epirubicin—uterine cancer	0.000164	0.00106	CcSEcCtD
Lovastatin—Erythema multiforme—Doxorubicin—uterine cancer	0.000162	0.00105	CcSEcCtD
Lovastatin—Diarrhoea—Etoposide—uterine cancer	0.000161	0.00104	CcSEcCtD
Lovastatin—Flushing—Doxorubicin—uterine cancer	0.000159	0.00103	CcSEcCtD
Lovastatin—Flatulence—Epirubicin—uterine cancer	0.000159	0.00103	CcSEcCtD
Lovastatin—Dysgeusia—Epirubicin—uterine cancer	0.000158	0.00102	CcSEcCtD
Lovastatin—Back pain—Epirubicin—uterine cancer	0.000156	0.00101	CcSEcCtD
Lovastatin—Dizziness—Etoposide—uterine cancer	0.000155	0.001	CcSEcCtD
Lovastatin—Muscle spasms—Epirubicin—uterine cancer	0.000155	0.001	CcSEcCtD
Lovastatin—Chills—Doxorubicin—uterine cancer	0.000154	0.000994	CcSEcCtD
Lovastatin—Vision blurred—Epirubicin—uterine cancer	0.000152	0.000982	CcSEcCtD
Lovastatin—Alopecia—Doxorubicin—uterine cancer	0.000152	0.000979	CcSEcCtD
Lovastatin—Ill-defined disorder—Epirubicin—uterine cancer	0.00015	0.000967	CcSEcCtD
Lovastatin—Vomiting—Etoposide—uterine cancer	0.000149	0.000964	CcSEcCtD
Lovastatin—Rash—Etoposide—uterine cancer	0.000148	0.000956	CcSEcCtD
Lovastatin—Dermatitis—Etoposide—uterine cancer	0.000148	0.000955	CcSEcCtD
Lovastatin—Headache—Etoposide—uterine cancer	0.000147	0.00095	CcSEcCtD
Lovastatin—Flatulence—Doxorubicin—uterine cancer	0.000147	0.00095	CcSEcCtD
Lovastatin—Dysgeusia—Doxorubicin—uterine cancer	0.000146	0.000944	CcSEcCtD
Lovastatin—Malaise—Epirubicin—uterine cancer	0.000146	0.000939	CcSEcCtD
Lovastatin—Vertigo—Epirubicin—uterine cancer	0.000145	0.000936	CcSEcCtD
Lovastatin—Leukopenia—Epirubicin—uterine cancer	0.000144	0.000933	CcSEcCtD
Lovastatin—Back pain—Doxorubicin—uterine cancer	0.000144	0.000932	CcSEcCtD
Lovastatin—Muscle spasms—Doxorubicin—uterine cancer	0.000144	0.000927	CcSEcCtD
Lovastatin—Vision blurred—Doxorubicin—uterine cancer	0.000141	0.000908	CcSEcCtD
Lovastatin—Nausea—Etoposide—uterine cancer	0.00014	0.000901	CcSEcCtD
Lovastatin—Ill-defined disorder—Doxorubicin—uterine cancer	0.000139	0.000894	CcSEcCtD
Lovastatin—Chest pain—Epirubicin—uterine cancer	0.000137	0.000887	CcSEcCtD
Lovastatin—Arthralgia—Epirubicin—uterine cancer	0.000137	0.000887	CcSEcCtD
Lovastatin—Myalgia—Epirubicin—uterine cancer	0.000137	0.000887	CcSEcCtD
Lovastatin—Anxiety—Epirubicin—uterine cancer	0.000137	0.000884	CcSEcCtD
Lovastatin—Discomfort—Epirubicin—uterine cancer	0.000136	0.000876	CcSEcCtD
Lovastatin—ABCB1—lymph node—uterine cancer	0.000135	0.00154	CbGeAlD
Lovastatin—Malaise—Doxorubicin—uterine cancer	0.000135	0.000869	CcSEcCtD
Lovastatin—Dry mouth—Epirubicin—uterine cancer	0.000134	0.000867	CcSEcCtD
Lovastatin—Vertigo—Doxorubicin—uterine cancer	0.000134	0.000866	CcSEcCtD
Lovastatin—Leukopenia—Doxorubicin—uterine cancer	0.000134	0.000863	CcSEcCtD
Lovastatin—Confusional state—Epirubicin—uterine cancer	0.000133	0.000857	CcSEcCtD
Lovastatin—Anaphylactic shock—Epirubicin—uterine cancer	0.000132	0.00085	CcSEcCtD
Lovastatin—Infection—Epirubicin—uterine cancer	0.000131	0.000845	CcSEcCtD
Lovastatin—Thrombocytopenia—Epirubicin—uterine cancer	0.000129	0.000832	CcSEcCtD
Lovastatin—Myalgia—Doxorubicin—uterine cancer	0.000127	0.000821	CcSEcCtD
Lovastatin—Arthralgia—Doxorubicin—uterine cancer	0.000127	0.000821	CcSEcCtD
Lovastatin—Chest pain—Doxorubicin—uterine cancer	0.000127	0.000821	CcSEcCtD
Lovastatin—Anxiety—Doxorubicin—uterine cancer	0.000127	0.000818	CcSEcCtD
Lovastatin—Discomfort—Doxorubicin—uterine cancer	0.000126	0.000811	CcSEcCtD
Lovastatin—Anorexia—Epirubicin—uterine cancer	0.000126	0.00081	CcSEcCtD
Lovastatin—Dry mouth—Doxorubicin—uterine cancer	0.000124	0.000803	CcSEcCtD
Lovastatin—Confusional state—Doxorubicin—uterine cancer	0.000123	0.000793	CcSEcCtD
Lovastatin—Anaphylactic shock—Doxorubicin—uterine cancer	0.000122	0.000787	CcSEcCtD
Lovastatin—Infection—Doxorubicin—uterine cancer	0.000121	0.000782	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00012	0.000775	CcSEcCtD
Lovastatin—Thrombocytopenia—Doxorubicin—uterine cancer	0.000119	0.00077	CcSEcCtD
Lovastatin—Insomnia—Epirubicin—uterine cancer	0.000119	0.000769	CcSEcCtD
Lovastatin—Paraesthesia—Epirubicin—uterine cancer	0.000118	0.000763	CcSEcCtD
Lovastatin—Dyspnoea—Epirubicin—uterine cancer	0.000117	0.000758	CcSEcCtD
Lovastatin—Anorexia—Doxorubicin—uterine cancer	0.000116	0.00075	CcSEcCtD
Lovastatin—Dyspepsia—Epirubicin—uterine cancer	0.000116	0.000748	CcSEcCtD
Lovastatin—Decreased appetite—Epirubicin—uterine cancer	0.000114	0.000739	CcSEcCtD
Lovastatin—Fatigue—Epirubicin—uterine cancer	0.000114	0.000733	CcSEcCtD
Lovastatin—Pain—Epirubicin—uterine cancer	0.000113	0.000727	CcSEcCtD
Lovastatin—Constipation—Epirubicin—uterine cancer	0.000113	0.000727	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000111	0.000717	CcSEcCtD
Lovastatin—Insomnia—Doxorubicin—uterine cancer	0.00011	0.000712	CcSEcCtD
Lovastatin—Paraesthesia—Doxorubicin—uterine cancer	0.000109	0.000706	CcSEcCtD
Lovastatin—Dyspnoea—Doxorubicin—uterine cancer	0.000109	0.000701	CcSEcCtD
Lovastatin—Feeling abnormal—Epirubicin—uterine cancer	0.000109	0.000701	CcSEcCtD
Lovastatin—Gastrointestinal pain—Epirubicin—uterine cancer	0.000108	0.000695	CcSEcCtD
Lovastatin—Dyspepsia—Doxorubicin—uterine cancer	0.000107	0.000693	CcSEcCtD
Lovastatin—Decreased appetite—Doxorubicin—uterine cancer	0.000106	0.000684	CcSEcCtD
Lovastatin—Fatigue—Doxorubicin—uterine cancer	0.000105	0.000678	CcSEcCtD
Lovastatin—Urticaria—Epirubicin—uterine cancer	0.000105	0.000675	CcSEcCtD
Lovastatin—Pain—Doxorubicin—uterine cancer	0.000104	0.000673	CcSEcCtD
Lovastatin—Constipation—Doxorubicin—uterine cancer	0.000104	0.000673	CcSEcCtD
Lovastatin—Body temperature increased—Epirubicin—uterine cancer	0.000104	0.000672	CcSEcCtD
Lovastatin—Abdominal pain—Epirubicin—uterine cancer	0.000104	0.000672	CcSEcCtD
Lovastatin—Feeling abnormal—Doxorubicin—uterine cancer	0.0001	0.000648	CcSEcCtD
Lovastatin—Gastrointestinal pain—Doxorubicin—uterine cancer	9.96e-05	0.000643	CcSEcCtD
Lovastatin—Hypersensitivity—Epirubicin—uterine cancer	9.7e-05	0.000626	CcSEcCtD
Lovastatin—Urticaria—Doxorubicin—uterine cancer	9.68e-05	0.000625	CcSEcCtD
Lovastatin—Body temperature increased—Doxorubicin—uterine cancer	9.63e-05	0.000622	CcSEcCtD
Lovastatin—Abdominal pain—Doxorubicin—uterine cancer	9.63e-05	0.000622	CcSEcCtD
Lovastatin—Asthenia—Epirubicin—uterine cancer	9.45e-05	0.00061	CcSEcCtD
Lovastatin—Pruritus—Epirubicin—uterine cancer	9.32e-05	0.000602	CcSEcCtD
Lovastatin—Diarrhoea—Epirubicin—uterine cancer	9.01e-05	0.000582	CcSEcCtD
Lovastatin—Hypersensitivity—Doxorubicin—uterine cancer	8.98e-05	0.00058	CcSEcCtD
Lovastatin—Asthenia—Doxorubicin—uterine cancer	8.74e-05	0.000564	CcSEcCtD
Lovastatin—Dizziness—Epirubicin—uterine cancer	8.71e-05	0.000562	CcSEcCtD
Lovastatin—Pruritus—Doxorubicin—uterine cancer	8.62e-05	0.000557	CcSEcCtD
Lovastatin—Vomiting—Epirubicin—uterine cancer	8.37e-05	0.000541	CcSEcCtD
Lovastatin—Diarrhoea—Doxorubicin—uterine cancer	8.34e-05	0.000538	CcSEcCtD
Lovastatin—Rash—Epirubicin—uterine cancer	8.3e-05	0.000536	CcSEcCtD
Lovastatin—Dermatitis—Epirubicin—uterine cancer	8.3e-05	0.000536	CcSEcCtD
Lovastatin—Headache—Epirubicin—uterine cancer	8.25e-05	0.000533	CcSEcCtD
Lovastatin—Dizziness—Doxorubicin—uterine cancer	8.06e-05	0.00052	CcSEcCtD
Lovastatin—Nausea—Epirubicin—uterine cancer	7.82e-05	0.000505	CcSEcCtD
Lovastatin—Vomiting—Doxorubicin—uterine cancer	7.75e-05	0.0005	CcSEcCtD
Lovastatin—Rash—Doxorubicin—uterine cancer	7.68e-05	0.000496	CcSEcCtD
Lovastatin—Dermatitis—Doxorubicin—uterine cancer	7.68e-05	0.000496	CcSEcCtD
Lovastatin—Headache—Doxorubicin—uterine cancer	7.63e-05	0.000493	CcSEcCtD
Lovastatin—Nausea—Doxorubicin—uterine cancer	7.24e-05	0.000467	CcSEcCtD
Lovastatin—ITGAL—Immune System—AKT1—uterine cancer	2.83e-05	0.000381	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.83e-05	0.00038	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—YWHAE—uterine cancer	2.79e-05	0.000375	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AKR1C1—uterine cancer	2.76e-05	0.000371	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—EP300—uterine cancer	2.75e-05	0.00037	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	2.74e-05	0.000368	CbGpPWpGaD
Lovastatin—HDAC2—Disease—SMAD3—uterine cancer	2.73e-05	0.000367	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—STAR—uterine cancer	2.72e-05	0.000366	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AKR1B1—uterine cancer	2.72e-05	0.000366	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—AKR1C3—uterine cancer	2.71e-05	0.000364	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—RRM2—uterine cancer	2.68e-05	0.000361	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—CYP11A1—uterine cancer	2.68e-05	0.00036	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—NDUFB11—uterine cancer	2.68e-05	0.00036	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SRD5A2—uterine cancer	2.68e-05	0.00036	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FBXW7—uterine cancer	2.67e-05	0.00036	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.67e-05	0.000359	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—NDUFB11—uterine cancer	2.65e-05	0.000357	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SRD5A2—uterine cancer	2.65e-05	0.000357	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—MTHFR—uterine cancer	2.63e-05	0.000353	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—AKT1—uterine cancer	2.62e-05	0.000353	CbGpPWpGaD
Lovastatin—HDAC2—Disease—FGFR2—uterine cancer	2.61e-05	0.00035	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—DCN—uterine cancer	2.6e-05	0.00035	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—VEGFA—uterine cancer	2.6e-05	0.00035	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.58e-05	0.000346	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—NRAS—uterine cancer	2.57e-05	0.000346	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—AKR1C3—uterine cancer	2.53e-05	0.00034	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MTHFR—uterine cancer	2.51e-05	0.000337	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—RRM2—uterine cancer	2.46e-05	0.000331	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CYP11A1—uterine cancer	2.45e-05	0.00033	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.43e-05	0.000327	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—STK11—uterine cancer	2.42e-05	0.000326	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—CYP19A1—uterine cancer	2.42e-05	0.000326	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—ESR1—uterine cancer	2.4e-05	0.000323	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—DCN—uterine cancer	2.39e-05	0.000321	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	2.38e-05	0.00032	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AKR1B1—uterine cancer	2.36e-05	0.000317	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—STAR—uterine cancer	2.36e-05	0.000317	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—STK11—uterine cancer	2.34e-05	0.000314	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.33e-05	0.000313	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—AKR1C3—uterine cancer	2.32e-05	0.000311	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.32e-05	0.000311	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CYP11A1—uterine cancer	2.25e-05	0.000303	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—KRAS—uterine cancer	2.21e-05	0.000298	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	2.21e-05	0.000297	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SOCS3—uterine cancer	2.19e-05	0.000294	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—MTHFR—uterine cancer	2.14e-05	0.000288	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—POLD1—uterine cancer	2.13e-05	0.000287	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AKR1C3—uterine cancer	2.13e-05	0.000286	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—STK11—uterine cancer	2.11e-05	0.000284	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—CYP19A1—uterine cancer	2.11e-05	0.000284	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AKR1B1—uterine cancer	2.1e-05	0.000283	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—STAR—uterine cancer	2.1e-05	0.000283	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CDKN2B—uterine cancer	2.1e-05	0.000282	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	2.08e-05	0.00028	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.08e-05	0.000279	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—STAR—uterine cancer	2.05e-05	0.000276	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AKR1B1—uterine cancer	2.05e-05	0.000276	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IGF1R—uterine cancer	2.03e-05	0.000274	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—PIK3CA—uterine cancer	2.03e-05	0.000273	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	2.03e-05	0.000273	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AKR1C1—uterine cancer	2e-05	0.000268	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.98e-05	0.000266	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—STK11—uterine cancer	1.97e-05	0.000265	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—CYP19A1—uterine cancer	1.97e-05	0.000265	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—TP53—uterine cancer	1.97e-05	0.000264	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.94e-05	0.00026	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—STAR—uterine cancer	1.93e-05	0.00026	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AKR1B1—uterine cancer	1.93e-05	0.00026	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.92e-05	0.000258	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—STAR—uterine cancer	1.92e-05	0.000258	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SMAD3—uterine cancer	1.91e-05	0.000257	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.9e-05	0.000255	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.89e-05	0.000254	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—HRAS—uterine cancer	1.88e-05	0.000253	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—POLD1—uterine cancer	1.85e-05	0.000249	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.83e-05	0.000247	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FGFR2—uterine cancer	1.82e-05	0.000245	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—MTHFR—uterine cancer	1.82e-05	0.000245	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CYP19A1—uterine cancer	1.8e-05	0.000243	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—STK11—uterine cancer	1.8e-05	0.000243	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—RRM2—uterine cancer	1.78e-05	0.000239	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.75e-05	0.000235	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.75e-05	0.000235	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.73e-05	0.000232	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—DCN—uterine cancer	1.73e-05	0.000232	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.69e-05	0.000228	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—AKT1—uterine cancer	1.66e-05	0.000223	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—STK11—uterine cancer	1.66e-05	0.000223	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CYP19A1—uterine cancer	1.66e-05	0.000223	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—POLD1—uterine cancer	1.65e-05	0.000222	CbGpPWpGaD
Lovastatin—HDAC2—Disease—ERBB2—uterine cancer	1.64e-05	0.00022	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CYP11A1—uterine cancer	1.63e-05	0.000219	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.62e-05	0.000217	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—POLD1—uterine cancer	1.61e-05	0.000217	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—MTHFR—uterine cancer	1.59e-05	0.000213	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ESR1—uterine cancer	1.56e-05	0.00021	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.56e-05	0.00021	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.54e-05	0.000208	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—RRM2—uterine cancer	1.54e-05	0.000207	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AKR1C3—uterine cancer	1.54e-05	0.000207	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—POLD1—uterine cancer	1.52e-05	0.000204	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CDKN1B—uterine cancer	1.52e-05	0.000204	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AKR1C1—uterine cancer	1.51e-05	0.000203	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—POLD1—uterine cancer	1.5e-05	0.000202	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—DCN—uterine cancer	1.5e-05	0.000201	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—MTHFR—uterine cancer	1.48e-05	0.000199	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PTEN—uterine cancer	1.46e-05	0.000197	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.43e-05	0.000193	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CTNNB1—uterine cancer	1.43e-05	0.000192	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AKR1C1—uterine cancer	1.42e-05	0.000191	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.41e-05	0.00019	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.41e-05	0.000189	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.4e-05	0.000188	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PTEN—uterine cancer	1.4e-05	0.000188	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—EP300—uterine cancer	1.39e-05	0.000187	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.39e-05	0.000186	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—RRM2—uterine cancer	1.38e-05	0.000185	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCL2—uterine cancer	1.37e-05	0.000185	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—MTHFR—uterine cancer	1.36e-05	0.000182	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—RRM2—uterine cancer	1.34e-05	0.000181	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—DCN—uterine cancer	1.34e-05	0.00018	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.33e-05	0.000179	CbGpPWpGaD
Lovastatin—HDAC2—Disease—EP300—uterine cancer	1.33e-05	0.000179	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—DCN—uterine cancer	1.3e-05	0.000175	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—RRM2—uterine cancer	1.27e-05	0.00017	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.26e-05	0.00017	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—STAR—uterine cancer	1.26e-05	0.00017	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CYP11A1—uterine cancer	1.26e-05	0.000169	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—RRM2—uterine cancer	1.25e-05	0.000169	CbGpPWpGaD
Lovastatin—HDAC2—Disease—NRAS—uterine cancer	1.24e-05	0.000167	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—MTHFR—uterine cancer	1.24e-05	0.000167	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—DCN—uterine cancer	1.23e-05	0.000165	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYP11A1—uterine cancer	1.23e-05	0.000165	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—DCN—uterine cancer	1.22e-05	0.000164	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CYP19A1—uterine cancer	1.2e-05	0.000161	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—STK11—uterine cancer	1.2e-05	0.000161	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.2e-05	0.000161	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PTEN—uterine cancer	1.19e-05	0.00016	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AKR1C3—uterine cancer	1.19e-05	0.00016	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.17e-05	0.000157	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AKR1C3—uterine cancer	1.16e-05	0.000156	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP11A1—uterine cancer	1.16e-05	0.000156	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.15e-05	0.000154	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ERBB2—uterine cancer	1.15e-05	0.000154	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—EP300—uterine cancer	1.14e-05	0.000153	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AKR1C3—uterine cancer	1.09e-05	0.000147	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CXCL8—uterine cancer	1.09e-05	0.000146	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.08e-05	0.000146	CbGpPWpGaD
Lovastatin—HDAC2—Disease—KRAS—uterine cancer	1.07e-05	0.000144	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CDKN1B—uterine cancer	1.06e-05	0.000143	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CYP19A1—uterine cancer	1.04e-05	0.000139	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—STK11—uterine cancer	1.04e-05	0.000139	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PIK3CA—uterine cancer	1.03e-05	0.000139	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PTEN—uterine cancer	1.01e-05	0.000136	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CTNNB1—uterine cancer	1e-05	0.000135	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—POLD1—uterine cancer	9.92e-06	0.000133	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PIK3CA—uterine cancer	9.84e-06	0.000132	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PTEN—uterine cancer	9.77e-06	0.000131	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.73e-06	0.000131	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—EP300—uterine cancer	9.66e-06	0.00013	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—EP300—uterine cancer	9.32e-06	0.000125	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.28e-06	0.000125	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AKR1C1—uterine cancer	9.28e-06	0.000125	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—STK11—uterine cancer	9.26e-06	0.000124	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CYP19A1—uterine cancer	9.26e-06	0.000124	CbGpPWpGaD
Lovastatin—HDAC2—Disease—HRAS—uterine cancer	9.11e-06	0.000122	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYP19A1—uterine cancer	9.03e-06	0.000121	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—STK11—uterine cancer	9.03e-06	0.000121	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—MTHFR—uterine cancer	9e-06	0.000121	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—VEGFA—uterine cancer	8.83e-06	0.000119	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTEN—uterine cancer	8.82e-06	0.000119	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NRAS—uterine cancer	8.72e-06	0.000117	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.69e-06	0.000117	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—AKT1—uterine cancer	8.66e-06	0.000116	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—STK11—uterine cancer	8.51e-06	0.000114	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP19A1—uterine cancer	8.51e-06	0.000114	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP19A1—uterine cancer	8.44e-06	0.000113	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—STK11—uterine cancer	8.44e-06	0.000113	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—AKT1—uterine cancer	8.42e-06	0.000113	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—EP300—uterine cancer	8.41e-06	0.000113	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PIK3CA—uterine cancer	8.41e-06	0.000113	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.29e-06	0.000111	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—RRM2—uterine cancer	8.27e-06	0.000111	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTEN—uterine cancer	8.23e-06	0.000111	CbGpPWpGaD
Lovastatin—HDAC2—Disease—AKT1—uterine cancer	8.04e-06	0.000108	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—DCN—uterine cancer	8.03e-06	0.000108	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.92e-06	0.000107	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—EP300—uterine cancer	7.85e-06	0.000106	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—MTHFR—uterine cancer	7.79e-06	0.000105	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP11A1—uterine cancer	7.57e-06	0.000102	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.56e-06	0.000102	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTEN—uterine cancer	7.54e-06	0.000101	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—KRAS—uterine cancer	7.5e-06	0.000101	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—EP300—uterine cancer	7.2e-06	9.67e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PIK3CA—uterine cancer	7.15e-06	9.61e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AKR1C3—uterine cancer	7.15e-06	9.61e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—MTHFR—uterine cancer	6.96e-06	9.35e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTEN—uterine cancer	6.92e-06	9.31e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PIK3CA—uterine cancer	6.89e-06	9.27e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.87e-06	9.23e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—AKT1—uterine cancer	6.87e-06	9.23e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—MTHFR—uterine cancer	6.79e-06	9.13e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TP53—uterine cancer	6.67e-06	8.97e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—EP300—uterine cancer	6.6e-06	8.88e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—MTHFR—uterine cancer	6.4e-06	8.6e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—HRAS—uterine cancer	6.38e-06	8.58e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—MTHFR—uterine cancer	6.34e-06	8.53e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PIK3CA—uterine cancer	6.22e-06	8.37e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.13e-06	8.24e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—AKT1—uterine cancer	5.84e-06	7.85e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CA—uterine cancer	5.81e-06	7.81e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AKT1—uterine cancer	5.63e-06	7.57e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.59e-06	7.52e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP19A1—uterine cancer	5.57e-06	7.48e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—STK11—uterine cancer	5.57e-06	7.48e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CA—uterine cancer	5.32e-06	7.16e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—AKT1—uterine cancer	5.08e-06	6.84e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTEN—uterine cancer	5.01e-06	6.73e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CA—uterine cancer	4.88e-06	6.57e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—EP300—uterine cancer	4.77e-06	6.42e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—AKT1—uterine cancer	4.74e-06	6.38e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—AKT1—uterine cancer	4.35e-06	5.85e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTEN—uterine cancer	4.34e-06	5.83e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—MTHFR—uterine cancer	4.18e-06	5.62e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—EP300—uterine cancer	4.13e-06	5.56e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AKT1—uterine cancer	3.99e-06	5.37e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTEN—uterine cancer	3.87e-06	5.2e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTEN—uterine cancer	3.78e-06	5.08e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—EP300—uterine cancer	3.69e-06	4.96e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—EP300—uterine cancer	3.6e-06	4.84e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTEN—uterine cancer	3.56e-06	4.79e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CA—uterine cancer	3.53e-06	4.75e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTEN—uterine cancer	3.53e-06	4.74e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—EP300—uterine cancer	3.39e-06	4.56e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—EP300—uterine cancer	3.36e-06	4.52e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CA—uterine cancer	3.06e-06	4.11e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AKT1—uterine cancer	2.88e-06	3.88e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CA—uterine cancer	2.73e-06	3.67e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CA—uterine cancer	2.66e-06	3.58e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CA—uterine cancer	2.51e-06	3.38e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AKT1—uterine cancer	2.5e-06	3.36e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CA—uterine cancer	2.49e-06	3.35e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTEN—uterine cancer	2.33e-06	3.13e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AKT1—uterine cancer	2.23e-06	3e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—EP300—uterine cancer	2.22e-06	2.98e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AKT1—uterine cancer	2.18e-06	2.93e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AKT1—uterine cancer	2.05e-06	2.76e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AKT1—uterine cancer	2.03e-06	2.73e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.64e-06	2.21e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AKT1—uterine cancer	1.34e-06	1.8e-05	CbGpPWpGaD
